Literature DB >> 27311721

Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).

R M R Pereira1, C P Figueiredo2, C C Cha2, V F Caparbo2, R M Oliveira3, A S Franco2, P R Menezes4, I de Castro5, L F Onuchic6.   

Abstract

This is the first study analyzing concomitantly osteoprotegerin (OPG)/receptor activator of nuclear factor kappa B ligand (RANKL) polymorphisms and OPG/RANKL serum levels and their association with bone mineral density (BMD), vertebral fractures, and vascular aortic calcification in a cohort of 800 subjects in community-dwelling older individuals.
INTRODUCTION: Osteoprotegerin (OPG) and RANKL play an important role in osteoclast activation and differentiation as well as in vascular calcification. At present, there are no studies of OPG or RANKL gene polymorphisms in Brazilian older populations. The aim of this study was to evaluate OPG/RANKL polymorphism and their association with vertebral fractures (VFs) and aortic calcification.
METHODS: Eight hundred subjects (497 women/303 men) were genotyped for the OPG 1181G>C (rs2073618), 163C>T (rs3102735), 245T>G (rs3134069), and 209G>A (rs3134070) and RANKL A>G (rs2277438) single-nucleotide polymorphisms (SNPs). VFs were evaluated by spine radiography (Genant's method). Aortic calcification was quantified using Kauppila's method.
RESULTS: The isolated genotype analyses and single-allele frequency data showed association of OPG 163C, 245G, and 209A alleles with presence of VFs (P < 0.05). Multiple logistic regression of subjects with absence of VFs vs. those with VFs (grades II/III) revealed only OPG 209A homozygosity as a risk factor for higher-grade VFs (odds ratio (OR) = 4.17, 95 % CI 1.03-16.93, P = 0.046). Regarding aortic calcification, the isolated genotype analysis frequency data revealed a significant association of OPG 1181G, 163C, 245G, and 209A alleles with absent aortic calcification (P < 0.05). Multiple logistic regression data confirmed that the OPG 209A allele was protective for aortic calcification (OR = 0.63, 95 % CI 0.45-0.88, P = 0.007) and the OPG 1181C allele was a risk factor for aortic calcification (OR = 1.26, 95 % CI 1.00-1.58, P = 0.046).
CONCLUSION: This study showed that the OPG 209AA genotype was a risk factor for higher-grade VFs, the OPG 209A allele was protective for aortic calcification, and the OPG 1181C was a risk factor for aortic calcification, supporting the involvement of OPG polymorphisms in the analyzed phenotypes and the concept that the related pathogenesis is multifactorial.

Entities:  

Keywords:  Aortic calcification; Osteoprotegerin; Polymorphism; RANKL; Vertebral fractures

Mesh:

Substances:

Year:  2016        PMID: 27311721     DOI: 10.1007/s00198-016-3664-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  50 in total

Review 1.  Minireview: the OPG/RANKL/RANK system.

Authors:  S Khosla
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

2.  Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.

Authors:  Barbara Arko; Janez Prezelj; Andreja Kocijancic; Radovan Komel; Janja Marc
Journal:  Maturitas       Date:  2005-07-16       Impact factor: 4.342

3.  Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density.

Authors:  Christopher Vidal; Robert Formosa; Angela Xuereb-Anastasi
Journal:  J Mol Endocrinol       Date:  2011-11-21       Impact factor: 5.098

4.  Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  Mol Genet Metab       Date:  2003-11       Impact factor: 4.797

5.  Osteoprotegerin gene polymorphisms in men with coronary artery disease.

Authors:  Muhidien Soufi; Michael Schoppet; Alexander M Sattler; Matthias Herzum; Bernhard Maisch; Lorenz C Hofbauer; Juergen R Schaefer
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Aortic calcification and the risk of osteoporosis and fractures.

Authors:  Eloy Schulz; Kiumars Arfai; Xiaodong Liu; James Sayre; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

7.  Bone morphogenetic protein expression in human atherosclerotic lesions.

Authors:  K Boström; K E Watson; S Horn; C Wortham; I M Herman; L L Demer
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.

Authors:  Jung Gu Kim; Jung Hwa Kim; Ja Yeon Kim; Seung Yup Ku; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Young Min Choi
Journal:  Menopause       Date:  2007 Sep-Oct       Impact factor: 2.953

9.  Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures.

Authors:  S Jurado; X Nogués; L Agueda; N Garcia-Giralt; R Urreizti; G Yoskovitz; L Pérez-Edo; G Saló; R Carreras; L Mellibovsky; S Balcells; D Grinberg; A Díez-Pérez
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

Review 10.  The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.

Authors:  P D'Amelio; G Isaia; G C Isaia
Journal:  J Endocrinol Invest       Date:  2009       Impact factor: 4.256

View more
  4 in total

1.  Toward personalized calcium and vitamin D supplementation.

Authors:  Roberto Civitelli; Timothy Peterson
Journal:  Am J Clin Nutr       Date:  2017-03-22       Impact factor: 7.045

2.  The association of OPG polymorphisms with risk of osteoporotic fractures: A systematic review and meta-analysis.

Authors:  Jianfeng Ding; Chongyang Zhang; Yuning Guo
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

3.  Common Variants in OPG Confer Risk to Bone Mineral Density Variation and Osteoporosis Fractures.

Authors:  Xiaoyong Sheng; Guangyong Cai; Xingjun Gong; Zouying Yao; Ye Zhu
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

4.  Association of TGFB1 rs1800469 and BCMO1 rs6564851 with coronary heart disease and IL1B rs16944 with all-cause mortality in men from the Northern Ireland PRIME study.

Authors:  Rachel E Mooney; Gerry J Linden; Lewis Winning; Katie Linden; Frank Kee; Pascal P McKeown; Jayne V Woodside; Christopher C Patterson; Gareth J McKay
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.